Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Coexpression and assembly of myosin heavy chain and myosin light chain in Escherichia coli.
Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities.
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Ann Oncol. 2016 05; 27(5):908-13.
View in:
PubMed
subject areas
Adult
Aged
Carcinoma, Squamous Cell
Chemoradiotherapy
Combined Modality Therapy
Everolimus
Female
Head and Neck Neoplasms
Humans
Induction Chemotherapy
Male
Middle Aged
Neoplasm Staging
Remission Induction
authors with profiles
Kerstin M. Stenson
Daniel Haraf
Elizabeth Blair
Ezra Cohen
Louis Portugal
Theodore Karrison